Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
IET Nanobiotechnol ; 11(8): 1052-1058, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29155407

ABSTRACT

The authors synthesised porous GdF3:Er3+,Yb3+-COOH core-shell structured bi-functional nanoparticles through a one-step hydrothermal route during which ethylene diamine tetraacetic acid) was bound to the surface of the nanoparticles. It has high up-conversion emission intensity for monitoring the drug release process and magnetisation saturation value (10.2 emu/g) for drug targeting under foreign magnetic fields. Moreover, porous GdF3:Er3+,Yb3+ as drug carriers with a high drug-loading efficiency. cis-Dichlorodiammineplatinum(II) (cisplatin, CDDP)-loaded GdF3:Er3+,Yb3+ nanoparticles (GdF3:Er3+,Yb3+-CDDP) were characterised by the Fourier transform infrared spectra, and CDDP was loaded in the form of electrostatic interaction and hydrogen bonds. Compared with CDDP alone, GdF3:Er3+,Yb3+-CDDP nanoparticles increase concentration of CDDP in the target site and enhance its anticancer efficiency. Therefore, the as-prepared GdF3:Er3+,Yb3+-COOH nanoparticles allow simultaneous targeted drug delivery and monitoring as promising anti-cancer theranostic agents.


Subject(s)
Drug Delivery Systems , Erbium/chemistry , Growth Differentiation Factor 3/administration & dosage , Nanoparticles/administration & dosage , Ytterbium/chemistry , Antineoplastic Agents/chemistry , Porosity
SELECTION OF CITATIONS
SEARCH DETAIL
...